microdosing glp-1 drugs GLP-1s: Risks & Considerations Microdosing GLP-1
Description
85% reduced fast food cravings
The current report aims to present an overview of current knowledge on GLP-1 RAs based on pragmatic review of the available clinical evidence
Thats why we created National Adverse Drug Event Awareness Day
But despite widespread use of these drugs by perimenopausal women, research has largely ignored the unique risks and potential opportunities for optimizing health that GLP-1s may pose for this population.
Their potential for disease modification and symptom relief, particularly in specific phenotypes, supports their further exploration as part of a personalized treatment approach.
